Kaplan–Meier survival analysis demonstrated higher overall survival rate in the UHRF2 high expression than in the UHRF2 low expression group (Fig. 1E), which indicate that high expression of UHRF2 is associated with poor prognosis in patients with HBV-associated HCC. The gene discussed is UHRF2; the disease is hepatocellular carcinoma.